IDEXX LABORATORIES INC /DE Derivative, Amount of Hedged Item
IDEXX LABORATORIES INC /DE (IDXX) had Derivative, Amount of Hedged Item of $80.00 million as of 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Derivative Instrument Detail
us-gaap:DerivativeAmountOfHedgedItem · last filed 2019-02-15
- 2018-12-31: Derivative, Amount of Hedged Item $80.00M.
- 2017-12-31: Derivative, Amount of Hedged Item $80.00M.
- 2016-12-31: Derivative, Amount of Hedged Item $80.00M.
- 2015-12-31: Derivative, Amount of Hedged Item $80.00M.
| Period end | Derivative, Amount of Hedged Item |
|---|---|
| 2018-12-31 | $80.00M 10-K · filed 2019-02-15 |
| 2017-12-31 | $80.00M 10-K · filed 2018-02-16 |
| 2016-12-31 | $80.00M 10-K · filed 2017-02-17 |
| 2015-12-31 | $80.00M 10-K · filed 2016-02-17 |
| 2014-12-31 | $80.00M 10-K · filed 2015-02-17 |
| 2014-09-30 | $80.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $80.00M 10-Q · filed 2014-07-25 |
| 2013-12-31 | $80.00M 10-K · filed 2014-02-18 |
| 2013-09-30 | $80.00M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $80.00M 10-Q · filed 2013-07-23 |
| 2011-09-30 | $80.00M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $80.00M 10-Q · filed 2011-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |